...
首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >Treatment of liver metastases of colorectal carcinoma: Overview of hyperthermal ablation methods [Therapie von Lebermetastasen des kolorektalen Karzinoms: übersicht der hyperthermen Ablationsverfahren]
【24h】

Treatment of liver metastases of colorectal carcinoma: Overview of hyperthermal ablation methods [Therapie von Lebermetastasen des kolorektalen Karzinoms: übersicht der hyperthermen Ablationsverfahren]

机译:大肠癌肝转移的治疗:高温消融方法概述

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim and method: This paper presents the basic techniques and clinical results of the most common hyperthermal ablation methods for patients with malignant liver metastases of colorectal carcinoma. An overview of recently published data is provided using selected articles from the literature and our own clinical experience in an interdisciplinary liver centre. Results: Radiofrequency ablation (RFA), microwave ablation (MWA) and laser ablation (LITT) show comparable results concerning survival data. Local recurrence is less frequent after LITT (7,1-10 %) than after RFA (32-44 %) and MWA (7-15 %). Survival depends on many factors. The 3-year survival rate for RFA ranges from 20,2-71,3 %, for MWA it is 51,1 % and for LITT from 56-77 %. Mean complication rates range from 1,8-10 %. Recent studies showed promising results after combined therapy of regional chemotherapy or regional radiotherapy with thermal ablation. Conclusion: Ablation methods such as RFA, MWA and LITT show good local tumor control with low complication rates and are usually performed on an outpatient basis. Indications are < 5 metastases limited to the liver with a maximum diameter of ≤ 4 cm when surgical resection is contraindicated or has been previously performed. The decision should be made by an interdisciplinary tumor board.
机译:目的和方法:本文介绍了结直肠癌恶性肝转移患者最常用的高温消融方法的基本技术和临床结果。使用文献中的精选文章以及我们在跨学科肝脏中心的临床经验,提供了最近发表数据的概述。结果:射频消融(RFA),微波消融(MWA)和激光消融(LITT)在生存数据方面显示出可比的结果。与RFA(32-44%)和MWA(7-15%)后相比,LITT(7.1- 10%)后局部复发的发生率较低。生存取决于许多因素。 RFA的3年生存率介于20,2-71,3%,MWA为51.1%,LITT为56-77%。平均并发症发生率在1.8%至10%之间。最近的研究表明,局部化疗或局部放疗与热消融联合治疗后,结果令人鼓舞。结论:RFA,MWA和LITT等消融方法显示出良好的局部肿瘤控制,并发症发生率低,通常在门诊进行。当禁忌或已进行手术切除时,适应症是<5个仅限于肝脏的转移灶,最大直径≤4 cm。该决定应由跨学科的肿瘤委员会做出。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号